0 XP   0   0   0

JB Chemicals & Pharmaceuticals Limited
Buy or Sell?

I guess you are interested in JB Chemicals & Pharmaceuticals Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's start. I'm going to help you getting a better view of JB Chemicals & Pharmaceuticals Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is JB Chemicals & Pharmaceuticals Limited even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how JB Chemicals & Pharmaceuticals Limited is doing in the market. If the company is worth buying. The latest step is to find out how other investors value JB Chemicals & Pharmaceuticals Limited. The closing price on 2022-09-23 was INR1,852 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Daily chart of JB Chemicals & Pharmaceuticals Limited
JB Chemicals & Pharmaceuticals Limited Daily Candlestick Chart

1.1. Profitability of JB Chemicals & Pharmaceuticals Limited.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin
  • Measures how much profit a company generates for each dollar of revenue.
  • Above 10% is considered healthy depending on the industry.
  • A net profit margin of 25% means that $0,25 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of JB Chemicals & Pharmaceuticals Limited:

  • The MRQ is 13.4%. Looks healthy. +1
  • The TTM is 14.4%. Looks healthy. +1
Trends
Current periodCompared to+/- 
MRQ13.4%TTM14.4%-1.0%
TTM14.4%YOY21.2%-6.9%
TTM14.4%5Y16.2%-1.9%
5Y16.2%10Y15.7%+0.5%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ13.4%1.2%+12.2%
TTM14.4%1.0%+13.4%
YOY21.2%1.7%+19.5%
5Y16.2%0.8%+15.4%
10Y15.7%1.4%+14.3%
1.1.2. Return on Assets
  • Shows how profitable a company is in relation to its total assets.
  • Above 5% is considered healthy depending on the industry.
  • 5% return on assets means the company generated $0,05 for each $1 in assets.

Let's take a look of the Return on Assets trends of JB Chemicals & Pharmaceuticals Limited:

  • The MRQ is 4.0%. Neutral. Compare to industry.
  • The TTM is 3.7%. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
MRQ4.0%TTM3.7%+0.3%
TTM3.7%YOY5.2%-1.5%
TTM3.7%5Y4.0%-0.3%
5Y4.0%10Y3.9%+0.1%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ4.0%0.2%+3.8%
TTM3.7%0.2%+3.5%
YOY5.2%0.1%+5.1%
5Y4.0%-0.1%+4.1%
10Y3.9%0.2%+3.7%
1.1.3. Return On Equity
  • Measures the profit in relation to shareholders equity (total assets - total liabilities).
  • Above 15%-20% is considered healthy depending on the industry
  • 10% return on equity means the company generated $0,1 for each $1 the owners (shareholders) invested.

Let's take a look of the Return On Equity trends of JB Chemicals & Pharmaceuticals Limited:

  • The MRQ is 4.9%. Bad. -1
  • The TTM is 4.5%. Bad. -1
Trends
Current periodCompared to+/- 
MRQ4.9%TTM4.5%+0.4%
TTM4.5%YOY6.5%-2.0%
TTM4.5%5Y4.9%-0.4%
5Y4.9%10Y4.9%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ4.9%0.8%+4.1%
TTM4.5%0.6%+3.9%
YOY6.5%0.7%+5.8%
5Y4.9%0.1%+4.8%
10Y4.9%0.5%+4.4%

1.2. Operating Efficiency of JB Chemicals & Pharmaceuticals Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin
  • Measures how much profit a company makes for each $1 of sales after paying variable costs (production costs, wages) but before taxes.
  • Above 15% is considered healthy depending on the industry
  • An operating margin of 20% means the company generated $0,2 for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of JB Chemicals & Pharmaceuticals Limited:

  • The MRQ is 18.7%. Good. +1
  • The TTM is 19.1%. Good. +1
Trends
Current periodCompared to+/- 
MRQ18.7%TTM19.1%-0.4%
TTM19.1%YOY28.5%-9.4%
TTM19.1%5Y22.0%-2.9%
5Y22.0%10Y21.1%+0.9%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ18.7%3.9%+14.8%
TTM19.1%2.3%+16.8%
YOY28.5%4.0%+24.5%
5Y22.0%3.5%+18.5%
10Y21.1%2.0%+19.1%
1.2.2. Operating Ratio
  • Measures how efficient the company is creating its products or services while keeping operating costs low.
  • Below 1 is considered healthy depending on the industry
  • An operation ratio of 0.5 means that the operating costs are $0,5 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of JB Chemicals & Pharmaceuticals Limited:

  • The MRQ is 1.186. Very good. +2
  • The TTM is 1.083. Very good. +2
Trends
Current periodCompared to+/- 
MRQ1.186TTM1.083+0.103
TTM1.083YOY0.764+0.319
TTM1.0835Y0.867+0.216
5Y0.86710Y0.861+0.006
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1861.486-0.300
TTM1.0831.442-0.359
YOY0.7641.386-0.622
5Y0.8671.364-0.497
10Y0.8611.160-0.299

1.3. Liquidity of JB Chemicals & Pharmaceuticals Limited.

1.3. Liquidity
1.3.1. Current Ratio
  • Measures if the company is able to pay off short-term debts (debts due within 1 year).
  • Above 1 is considered healthy depending on the industry.
  • A current ratio of 1.5 means the company has $1.5 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of JB Chemicals & Pharmaceuticals Limited:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM2.145-2.145
TTM2.145YOY2.112+0.033
TTM2.1455Y1.688+0.457
5Y1.68810Y1.665+0.023
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.872-1.872
TTM2.1451.896+0.249
YOY2.1122.071+0.041
5Y1.6882.123-0.435
10Y1.6651.805-0.140
1.3.2. Quick Ratio
  • Measures if the company is able to pay short-term debts (debts due within 1 year). But only uses the most liquid assets (cash, marketable securities and accounts retrievable).
  • Above 1 is considered healthy depending on the industry.
  • A quick ratio of 0,8 means the company can pay off $0,8 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of JB Chemicals & Pharmaceuticals Limited:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1.999-1.999
TTM1.999YOY2.262-0.263
TTM1.9995Y1.732+0.266
5Y1.73210Y1.602+0.131
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.630-0.630
TTM1.9990.773+1.226
YOY2.2620.782+1.480
5Y1.7320.806+0.926
10Y1.6020.808+0.794

1.4. Solvency of JB Chemicals & Pharmaceuticals Limited.

1.3. Liquidity
1.4.1. Debt To Asset Ratio
  • Shows if the company is owned by creditors or shareholders.
  • Below 1 (100%) is considered healthy depending on the industry
  • A debt to asset ratio of 0.45 (45%) means that the company is financed with 45% credit and 55% is financed by it's owners (shareholders).

Let's take a look of the Debt To Asset Ratio trends of JB Chemicals & Pharmaceuticals Limited:

  • The MRQ is 0.182. Very good. +2
  • The TTM is 0.180. Very good. +2
Trends
Current periodCompared to+/- 
MRQ0.182TTM0.180+0.001
TTM0.180YOY0.198-0.018
TTM0.1805Y0.188-0.008
5Y0.18810Y0.200-0.011
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1820.429-0.247
TTM0.1800.413-0.233
YOY0.1980.391-0.193
5Y0.1880.393-0.205
10Y0.2000.396-0.196
1.4.2. Debt to Equity Ratio
  • Measures the total debt versus the total shareholders equity (total assets - total liabilities).
  • Below 2 is considered healthy depending on the industry.
  • A debt to equity ratio of 0.84 means that company has $0,84 debt for each $1 in equity.

Let's take a look of the Debt to Equity Ratio trends of JB Chemicals & Pharmaceuticals Limited:

  • The MRQ is 0.222. Very good. +2
  • The TTM is 0.220. Very good. +2
Trends
Current periodCompared to+/- 
MRQ0.222TTM0.220+0.001
TTM0.220YOY0.248-0.028
TTM0.2205Y0.231-0.010
5Y0.23110Y0.251-0.020
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2220.697-0.475
TTM0.2200.678-0.458
YOY0.2480.624-0.376
5Y0.2310.683-0.452
10Y0.2510.686-0.435

2. Market Valuation of JB Chemicals & Pharmaceuticals Limited

2. Earnings
2.1. Price to Earnings Ratio
  • Compares the company's stock price to its earnings.
  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of 15 means the investor is paying $15 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of JB Chemicals & Pharmaceuticals Limited:

  • The EOD is 38.543. Seems overpriced? -1
  • The MRQ is 32.738. Seems overpriced? -1
  • The TTM is 32.138. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD38.543MRQ32.738+5.805
MRQ32.738TTM32.138+0.600
TTM32.138YOY23.768+8.371
TTM32.1385Y23.475+8.664
5Y23.47510Y19.954+3.521
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD38.5430.263+38.280
MRQ32.7380.392+32.346
TTM32.1381.360+30.778
YOY23.7683.640+20.128
5Y23.4756.020+17.455
10Y19.9546.546+13.408
2.2. Price/Earnings-to-Growth Ratio

Let's take a look of the Price/Earnings-to-Growth Ratio trends of JB Chemicals & Pharmaceuticals Limited:

  • The MRQ is -1.924. Very Bad. -2
  • The TTM is 8.902. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ-1.924TTM8.902-10.826
TTM8.902YOY0.597+8.305
TTM8.9025Y2.989+5.913
5Y2.98910Y2.9890.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.9240.003-1.927
TTM8.9020.019+8.883
YOY0.5970.032+0.565
5Y2.9890.024+2.965
10Y2.9890.027+2.962

2. Books
2.3. Price to Book Ratio
  • Shows if the stock is under or overvalued compared to it's book value (total assets - total liabilities).
  • At or below 1 is considered healthy
  • A PB ratio of 3 means the investor is paying $3 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of JB Chemicals & Pharmaceuticals Limited:

  • The EOD is 6.705. Seems overpriced? -1
  • The MRQ is 5.695. Seems overpriced? -1
  • The TTM is 6.370. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD6.705MRQ5.695+1.010
MRQ5.695TTM6.370-0.675
TTM6.370YOY5.491+0.879
TTM6.3705Y3.947+2.424
5Y3.94710Y3.679+0.267
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD6.7051.440+5.265
MRQ5.6951.615+4.080
TTM6.3702.041+4.329
YOY5.4912.274+3.217
5Y3.9471.997+1.950
10Y3.6791.517+2.162

3. Summary

3.1. Key Performance Indicators

The key performance indicators of JB Chemicals & Pharmaceuticals Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--276.147266.207+4%222.685+24%211.342+31%195.350+41%
Current Ratio---2.145-100%2.112-100%1.688-100%1.665-100%
Debt To Asset Ratio--0.1820.180+1%0.198-8%0.188-4%0.200-9%
Debt To Equity Ratio--0.2220.220+1%0.248-11%0.231-4%0.251-12%
Eps--13.59012.009+13%14.472-6%10.543+29%8.961+52%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin--0.1340.144-7%0.212-37%0.162-17%0.157-15%
Operating Margin--0.1870.191-2%0.285-34%0.220-15%0.211-11%
Operating Ratio--1.1861.083+9%0.764+55%0.867+37%0.861+38%
Pb Ratio6.705+15%5.6956.370-11%5.491+4%3.947+44%3.679+55%
Pe Ratio38.543+15%32.73832.138+2%23.768+38%23.475+39%19.954+64%
Peg Ratio---1.9248.902-122%0.597-422%2.989-164%2.989-164%
Price Per Share1851.500+15%1572.6501689.125-7%1231.513+28%898.882+75%797.645+97%
Quick Ratio---1.999-100%2.262-100%1.732-100%1.602-100%
Return On Assets--0.0400.037+9%0.052-23%0.040+1%0.039+3%
Return On Equity--0.0490.045+9%0.065-25%0.049+0%0.049+0%
 EOD+0 -3MRQTTM+7 -8YOY+4 -115Y+7 -810Y+7 -8

3.2. Fundamental Score

Let's check the fundamental score of JB Chemicals & Pharmaceuticals Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1538.543
Price to Book Ratio (EOD)Between0-16.705
Net Profit Margin (MRQ)Greater than00.134
Operating Margin (MRQ)Greater than00.187
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than10.000
Debt To Asset Ratio (MRQ)Less than10.182
Debt to Equity Ratio (MRQ)Less than10.222
Return On Equity (MRQ)Greater than0.150.049
Return on Assets (MRQ)Greater than0.050.040
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of JB Chemicals & Pharmaceuticals Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.210
Ma 20Greater thanMa 501,866.298
Ma 50Greater thanMa 1001,798.318
Ma 100Greater thanMa 2001,686.697
OpenGreater thanClose1,881.000
Total5/5 (100.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in INR. All numbers in thousands.

Summary
 As reported
Total Liabilities -
Total Stockholder Equity+ -
Total Assets = -

Assets

Total Current Assets
Total Current Assets  (as reported)0
Total Current Assets  (calculated)0
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities
Total Current Liabilities  (as reported)0
Total Current Liabilities  (calculated)0
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)0
Total Stockholder Equity (calculated)0
+/-0
Other
Net Tangible Assets 14,052,694



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-03-312016-03-312013-06-302012-06-302005-03-31
> Total Assets 
4,113,062
0
0
15,573,841
16,740,386
0
0
0
17,910,005
0
19,558,225
0
18,135,611
0
20,536,432
0
22,381,152
0
24,168,814
0
26,074,022
0
026,074,022024,168,814022,381,152020,536,432018,135,611019,558,225017,910,00500016,740,38615,573,841004,113,062
   > Total Current Assets 
2,736,478
0
0
7,777,566
7,948,902
0
0
0
10,495,753
0
12,186,679
0
10,727,284
0
13,657,783
0
15,526,024
0
17,192,620
0
12,748,550
0
012,748,550017,192,620015,526,024013,657,783010,727,284012,186,679010,495,7530007,948,9027,777,566002,736,478
       Cash And Cash Equivalents 
94,913
0
0
149,567
133,864
0
0
0
353,968
0
338,906
0
290,079
0
343,694
0
286,855
0
353,447
0
585,279
0
0585,2790353,4470286,8550343,6940290,0790338,9060353,968000133,864149,5670094,913
       Short-term Investments 
0
0
0
1,952,497
2,261,021
0
0
0
3,606,499
0
5,396,875
0
3,338,126
0
4,610,833
0
6,649,748
0
7,367,394
0
433,230
0
0433,23007,367,39406,649,74804,610,83303,338,12605,396,87503,606,4990002,261,0211,952,497000
       Net Receivables 
1,986,483
0
0
0
0
0
0
0
3,092,953
0
3,331,813
0
3,565,085
0
4,114,129
0
3,992,416
0
4,720,986
0
5,981,177
0
05,981,17704,720,98603,992,41604,114,12903,565,08503,331,81303,092,95300000001,986,483
       Inventory 
527,839
0
0
1,879,833
2,001,686
0
0
0
2,437,576
0
2,420,163
0
2,746,697
0
3,776,216
0
3,474,468
0
3,630,614
0
4,099,611
0
04,099,61103,630,61403,474,46803,776,21602,746,69702,420,16302,437,5760002,001,6861,879,83300527,839
       Other Current Assets 
127,243
0
0
3,795,669
3,552,331
0
0
0
4,097,710
0
4,030,735
0
4,352,382
0
4,927,040
0
5,114,953
0
5,841,165
0
1,980,856
0
01,980,85605,841,16505,114,95304,927,04004,352,38204,030,73504,097,7100003,552,3313,795,66900127,243
   > Long-term Assets 
0
0
0
7,796,275
8,791,484
0
0
0
7,414,252
0
7,371,546
0
7,408,327
0
6,878,649
0
6,855,128
0
6,976,194
0
13,325,472
0
013,325,47206,976,19406,855,12806,878,64907,408,32707,371,54607,414,2520008,791,4847,796,275000
       Property Plant Equipment 
1,347,490
0
0
5,018,973
6,010,328
0
0
0
5,595,066
0
5,820,186
0
5,841,966
0
5,773,275
0
5,696,550
0
5,753,717
0
5,668,159
0
05,668,15905,753,71705,696,55005,773,27505,841,96605,820,18605,595,0660006,010,3285,018,973001,347,490
       Goodwill 
0
0
0
0
0
0
0
0
531,400
0
531,400
0
531,400
0
574,592
0
574,592
0
574,592
0
574,592
0
0574,5920574,5920574,5920574,5920531,4000531,4000531,40000000000
       Long Term Investments 
29,008
0
0
0
0
0
0
0
0
0
674,706
0
0
0
0
0
0
0
0
0
0
0
00000000000674,70600000000029,008
       Intangible Assets 
0
0
0
0
0
0
0
0
233,775
0
228,531
0
300,924
0
305,868
0
321,052
0
323,991
0
6,713,944
0
06,713,9440323,9910321,0520305,8680300,9240228,5310233,77500000000
       Long-term Assets Other 
0
0
0
2,187,766
2,297,141
0
0
0
3,700,172
0
5,513,598
0
3,376,295
0
4,705,320
0
6,712,312
0
7,437,166
0
121,606
0
0121,60607,437,16606,712,31204,705,32003,376,29505,513,59803,700,1720002,297,1412,187,766000
> Total Liabilities 
1,271,394
0
0
4,620,564
3,082,084
0
0
0
3,080,748
0
3,691,935
0
3,755,708
0
4,247,948
0
4,246,853
0
4,334,401
0
4,732,792
0
04,732,79204,334,40104,246,85304,247,94803,755,70803,691,93503,080,7480003,082,0844,620,564001,271,394
   > Total Current Liabilities 
897,822
0
0
4,357,995
2,812,084
0
0
0
2,432,357
0
3,104,643
0
3,128,460
0
3,457,049
0
3,452,737
0
3,270,121
0
3,837,156
0
03,837,15603,270,12103,452,73703,457,04903,128,46003,104,64302,432,3570002,812,0844,357,99500897,822
       Short-term Debt 
39,800
0
0
1,930,237
488,603
0
0
0
257,977
0
471,139
0
369,891
0
305,699
0
398,465
0
327,042
0
0
0
000327,0420398,4650305,6990369,8910471,1390257,977000488,6031,930,2370039,800
       Short Long Term Debt 
39,800
0
0
0
0
0
0
0
257,977
0
471,139
0
320,361
0
305,699
0
326,446
0
264,410
0
263,150
0
0263,1500264,4100326,4460305,6990320,3610471,1390257,977000000039,800
       Accounts payable 
204,177
0
0
11,617
989,771
0
0
0
827,606
0
1,074,273
0
1,237,925
0
1,451,223
0
1,869,234
0
1,906,005
0
2,244,797
0
02,244,79701,906,00501,869,23401,451,22301,237,92501,074,2730827,606000989,77111,61700204,177
       Other Current Liabilities 
258,814
0
0
2,416,141
1,333,710
0
0
0
1,346,774
0
1,559,231
0
1,520,644
0
1,700,127
0
1,185,038
0
1,037,074
0
1,005,519
0
01,005,51901,037,07401,185,03801,700,12701,520,64401,559,23101,346,7740001,333,7102,416,14100258,814
   > Long-term Liabilities 
0
0
0
262,569
270,000
0
0
0
648,391
0
587,292
0
627,248
0
790,899
0
794,116
0
1,064,280
0
850,737
0
0850,73701,064,2800794,1160790,8990627,2480587,2920648,391000270,000262,569000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
12,292
0
70,542
0
51,414
0
268,554
0
206,176
0
0206,1760268,554051,414070,542012,292000000000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
0
61,822
0
0
0
123,433
0
290,271
0
282,438
0
0282,4380290,2710123,43300061,822000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
22,029
0
46,191
0
59,684
0
51,805
0
49,322
0
40,915
0
31,664
0
031,664040,915049,322051,805059,684046,191022,02900000000
       Deferred Long Term Liability 
86
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000086
> Total Stockholder Equity
2,841,668
0
0
10,937,317
13,636,497
14,415,580
0
0
14,801,224
14,801,224
15,837,283
15,837,283
14,354,893
0
16,259,784
0
18,097,248
0
19,795,061
0
21,341,230
0
021,341,230019,795,061018,097,248016,259,784014,354,89315,837,28315,837,28314,801,22414,801,2240014,415,58013,636,49710,937,317002,841,668
   Common Stock
160,590
0
0
169,640
169,640
0
0
0
160,473
0
160,473
0
154,564
0
154,564
0
154,564
0
154,564
0
154,564
0
0154,5640154,5640154,5640154,5640154,5640160,4730160,473000169,640169,64000160,590
   Retained Earnings 
2,598,049
0
0
5,405,686
0
0
0
0
11,024,320
0
15,676,810
0
12,329,467
0
16,105,220
0
15,847,935
0
19,640,497
0
19,933,326
0
019,933,326019,640,497015,847,935016,105,220012,329,467015,676,810011,024,32000005,405,686002,598,049
   Capital Surplus 0000000000000000000000
   Treasury Stock0000000000000000000000
   Other Stockholders Equity 
71,024
0
0
8,420,083
13,466,857
0
0
0
8,150,888
0
15,676,810
0
7,024,964
0
16,105,220
0
2,094,749
0
19,640,497
0
745,658
0
0745,658019,640,49702,094,749016,105,22007,024,964015,676,81008,150,88800013,466,8578,420,0830071,024



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2022-03-31)

Gross Profit (+$)
totalRevenue24,242,438
Cost of Revenue-8,429,341
Gross Profit15,813,09715,813,097
 
Operating Income (+$)
Gross Profit15,813,097
Operating Expense-19,534,476
Operating Income4,707,962-3,721,379
 
Operating Expense (+$)
Research Development-
Selling General Administrative4,392,422
Selling And Marketing Expenses-
Operating Expense19,534,4764,392,422
 
Net Interest Income (+$)
Interest Income-51,205
Interest Expense-51,205
Net Interest Income-51,205-102,410
 
Pretax Income (+$)
Operating Income4,707,962
Net Interest Income-51,205
Other Non-Operating Income Expenses-
Income Before Tax (EBT)5,049,0204,707,962
EBIT - interestExpense = 4,691,741
5,042,205
3,904,779
Interest Expense51,205
Earnings Before Interest and Taxes (ebit)4,742,9465,100,225
Earnings Before Interest and Taxes (ebitda)5,826,824
 
After tax Income (+$)
Income Before Tax5,049,020
Tax Provision-1,188,631
Net Income From Continuing Ops3,860,3893,860,389
Net Income3,853,574
Net Income Applicable To Common Shares3,853,574
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses4,455,946
Total Other Income/Expenses Net-51,205
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
DAAPL.CC
8 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of DAAPL.CC.

DAAPL.CC Daily Candlestick Chart
UIP.CC
9 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of UIP.CC.

UIP.CC Daily Candlestick Chart
TRC.CC
9 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of TRC.CC.

TRC.CC Daily Candlestick Chart
TIX.CC
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TIX.CC.

TIX.CC Daily Candlestick Chart
THC.CC
9 hours ago

I found you a MACD Bearish Reversal Divergence on the daily chart of THC.CC.

THC.CC Daily Candlestick Chart
TERC.CC
9 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of TERC.CC.

TERC.CC Daily Candlestick Chart
RENTBERRY.CC
9 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of RENTBERRY.CC.

RENTBERRY.CC Daily Candlestick Chart
TBTC.CC
9 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of TBTC.CC.

TBTC.CC Daily Candlestick Chart
SWACE.CC
9 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SWACE.CC.

SWACE.CC Daily Candlestick Chart
START.CC
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of START.CC.

START.CC Daily Candlestick Chart
SNC.CC
9 hours ago

I found you a Death Cross on the daily chart of SNC.CC.

SNC.CC Daily Candlestick Chart
SAVG.CC
9 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of SAVG.CC.

SAVG.CC Daily Candlestick Chart
RPZX.CC
9 hours ago

I found you a Golden Cross on the daily chart of RPZX.CC.

RPZX.CC Daily Candlestick Chart
RIO.CC
9 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of RIO.CC.

RIO.CC Daily Candlestick Chart
PYRK.CC
9 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of PYRK.CC.

PYRK.CC Daily Candlestick Chart
PLAY.CC
9 hours ago

I found you a MACD Bullish Hidden Divergence on the daily chart of PLAY.CC.

PLAY.CC Daily Candlestick Chart
pBTC35A.CC
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of pBTC35A.CC.

pBTC35A.CC Daily Candlestick Chart
PBTC.CC
9 hours ago

I found you a MACD Bearish Reversal Divergence on the daily chart of PBTC.CC.

PBTC.CC Daily Candlestick Chart
PASC.CC
9 hours ago

I found you a Golden Cross on the daily chart of PASC.CC.

PASC.CC Daily Candlestick Chart
OPCT.CC
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of OPCT.CC.

OPCT.CC Daily Candlestick Chart
NCDT.CC
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NCDT.CC.

NCDT.CC Daily Candlestick Chart
MSWAP.CC
9 hours ago

I found you a Death Cross on the daily chart of MSWAP.CC.

MSWAP.CC Daily Candlestick Chart
MERI.CC
9 hours ago

I found you a MACD Bearish Reversal Divergence on the daily chart of MERI.CC.

MERI.CC Daily Candlestick Chart
MBC.CC
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of MBC.CC.

MBC.CC Daily Candlestick Chart